Bayer's Trasylol Woes Trigger First Liability Suit

Law360, New York (January 26, 2007, 12:00 AM EST) -- Boosting controversy over Bayer AG’s Trasylol product, a federal lawsuit accuses the German drug giant of concealing the results of a study that showed the bleeding-reduction drug could cause kidney failure.

The lawsuit alleges Bayer fraudulently withheld the study data from the U.S. Food and Drug Administration late last year, even as the agency was actively looking for new evidence of side effects based on an earlier tip from a medical journal.

The drug has been popular for stemming bleeding during open-heart surgery, so the potential...
To view the full article, register now.